Market closed

Stevanato Group/$STVN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Stevanato Group

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Ticker

$STVN
Sector
Health Care

Trading on

NYSE

Industry

Life Sciences Tools & Services

Headquarters

Piombino Dese, Italy

Employees

5,635
Website
www.stevanatogroup.com

Stevanato Group Metrics

BasicAdvanced
$6B
50.21
$0.44
0.56
$0.05
0.24%

$6B

0.56

$34.73

$16.56

369K

$0.05

1.81

1.207

21.884

27.602

21.72%

30.27%

4.96%

9.48%

50.214

5.264

4.52

4.83

-30.772

0.24%

0.24%

3.53%

-23.94%

10.18%

-5.17%

-93.88%

What the Analysts think about Stevanato Group

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Stevanato Group stock.

Stevanato Group Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Stevanato Group Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Stevanato Group News

AllArticlesVideos
Stevanato Group to Present at Upcoming Investor Conference

Stevanato Group to Present at Upcoming Investor Conference

Business Wire·1 week ago
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement

Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement

Seeking Alpha·2 months ago
Stevanato Group to Present at Upcoming Investor Conferences

Stevanato Group to Present at Upcoming Investor Conferences

Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $STVN

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Stevanato Group stock?

Stevanato Group (STVN) has a market cap of $6B as of January 15, 2025.

What is the P/E ratio for Stevanato Group stock?

The price to earnings (P/E) ratio for Stevanato Group (STVN) stock is 50.21 as of January 15, 2025.

Does Stevanato Group stock pay dividends?

Yes, the Stevanato Group (STVN) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $0.053 and the yield is 0.24%. Stevanato Group has a payout ratio of 21.72% on a trailing twelve-month basis.

When is the next Stevanato Group dividend payment date?

The next Stevanato Group (STVN) dividend payment date is unconfirmed.

What is the beta indicator for Stevanato Group?

Stevanato Group (STVN) has a beta rating of 0.56. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.